These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18405411

  • 41. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ, Macleod BA, Dumont GA, Bouzane AM, Schwarz SK.
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG.
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [Abstract] [Full Text] [Related]

  • 47. Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular block.
    Kern SE, Fragen RJ, Fitzgerald PC, van Zeeland M, Johnson JO.
    Can J Anaesth; 2001 Feb; 48(2):129-32. PubMed ID: 11220420
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy.
    Muenster T, Forst J, Goerlitz P, Schmitt HJ.
    Paediatr Anaesth; 2008 Mar; 18(3):251-5. PubMed ID: 18230069
    [Abstract] [Full Text] [Related]

  • 53. Effects of SZ1677, a new non-depolarizing steroidal neuromuscular blocking drug, and rocuronium on two laryngeal muscles and the anterior tibial muscle in guinea pigs.
    Michalek-Sauberer A, Nicolakis EM, Vizi ES, Gilly H.
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):481-7. PubMed ID: 16548861
    [Abstract] [Full Text] [Related]

  • 54. The effect of cisatracurium and rocuronium on lung function in anesthetized children.
    Yang CI, Fine GF, Jooste EH, Mutich R, Walczak SA, Motoyama EK.
    Anesth Analg; 2013 Dec; 117(6):1393-400. PubMed ID: 24257390
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Economic aspects of different muscle relaxant regimens.
    Suttner S, Boldt J, Piper SN, Schmidt C, Kumle B.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 May; 35(5):300-5. PubMed ID: 10858839
    [Abstract] [Full Text] [Related]

  • 57. Xylazine premedication does not modify the onset and duration of cisatracurium blockade in anaesthetized dogs.
    Kariman A, Shahabeddin M.
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):254-6. PubMed ID: 17523959
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF, Merry AF, Pawley MD, de Souza RL, Warman GR.
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.